Tang 2009.
Study characteristics | |||
Patient sampling | Primary objective: to investigate the possible roles of cyclin B1, cyclin‐dependent kinase (cdc2) and Polo‐like kinase 1 (Plk1) in the pathogenesis of endometriosis Participants: women who were undergoing laparoscopic surgery or hysterectomy Selection criteria: inclusion criteria: regular menstrual cycles (21–35 days), not on hormonal treatment, not pregnant, not breastfeeding, and not using IUD in the past 6/12 months; exclusion criteria: PID, adenomyosis, DUB Study design: observational study, two‐gate design, prospective sample collection |
||
Patient characteristics and setting | Clinical presentation: not specified Age: range 24‐46 years Number enrolled: 59 women Number available for analysis: 50 women (27 in proliferative and 23 in secretory cycle phase) Setting: university hospital ‐ Women’s Hospital of Zhejiang University Medical School Place of study: Hangzhou, Zhejiang, China Period of study: 2005‐2006 Language: English |
||
Index tests | Index test: cyclin B1, cdc2, Plk1 mRNA and protein Description of positive case definition by index test as reported: mRNA expression by RT‐PCR (using multiscribe reverse transcriptase (Invitrogen), single tube reaction with amplification; β‐actin gene used as internal reference); protein levels detected by Western Blot (Bradford assay (Bio‐Rad Laboratories, CA), normalised to β‐actin); laboratory technique described; thresholds not provided Examiners: none stated; unclear if blinded to the result of reference standard Interobserver variability: not reported |
||
Target condition and reference standard(s) | Target condition: endometriosis Prevalence of target condition in the sample: n/N = 20/50 (40%): all stages II‐III; controls 30 Reference standard: laparoscopy/laparotomy Description of positive case definition by reference test as reported: staging according to rAFS Examiners: none stated |
||
Flow and timing | Time interval between index test and reference standard: not stated; the context suggests timing around surgery Withdrawals: 9 participants were not included in the analyses, reasons not explained |
||
Comparative | |||
Notes | Conclusion: the increased expression of cyclin B1, cdc2, and Plk1 in ectopic endometrium may be involved in the up‐regulated proliferation activity and neoplastic features of endometriosis. Comment: For Cyclin B1, cdc2, Plk1 mRNA and protein, there was no statistically significant difference between the groups ‐ no data available for meta‐analysis (Appendix 7) |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Was a 'two‐gate' design avoided? | No | ||
High | High | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | No | ||
Was a menstrual cycle phase considered in interpreting the index test | Yes | ||
High | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | No | ||
High |